Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul-Aug;41(4):412-416.
doi: 10.1016/j.nefroe.2021.09.001. Epub 2021 Sep 22.

Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines

Emilio Sánchez-Álvarez  1 , Borja Quiroga  2 , Patricia de Sequera  3 ; en representación de la Junta Directiva de Sociedad Española de Nefrología
Affiliations

Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines

Emilio Sánchez-Álvarez et al. Nefrologia (Engl Ed). 2021 Jul-Aug.

Abstract
in English, Spanish

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide over the last year causing more than one million deaths. Several treatments have tried to modify the natural history of the coronavirus disease 2019 (COVID-19) but only corticosteroids have demonstrated to be effective in moderate or severe affectation. In that situation, the development of vaccines for preventing the SARS-CoV-2 infection has focused the attention of the scientific community. At present, available messenger RNA-based technology vaccines have received the approval of local and international sanitary authorities. In this position statement, the Spanish Society of Nephrology wants to state that patients with chronic kidney disease and healthcare workers are at high-risk for contagion and complications of COVID-19 so they must have priority in the vaccine administration.

La expansión de la pandemia por el coronavirus de tipo 2 causante del síndrome respiratorio agudo severo (SARS-CoV-2) ha ocasionado más de un millón de muertos en todo el planeta. Un año después de su irrupción, numerosos tratamientos se han postulado sin llegar a alcanzarse resultados clínicamente significativos, a excepción de los corticoides en pacientes con afectación moderada-severa de la enfermedad por coronavirus 19 (COVID-19). En este escenario, la prevención mediante vacunas ha centrado la atención de la comunidad científica. En el momento actual, disponemos de las primeras aprobaciones para el uso de vacunas basadas en ARN mensajero y las agencias locales e internacionales se disponen de manera inminente a su aprobación. Dado que la infección por COVID-19 es frecuente en los pacientes con enfermedad renal terminal y condiciona una elevada mortalidad, desde la Sociedad Española de Nefrología consideramos que los pacientes con enfermedad renal y los profesionales que los atienden deben considerarse prioritarios para recibir la vacuna por su elevado riesgo de contagio y morbi-mortalidad.

Keywords: COVID-19; Chronic kidney disease; Dialysis; Diálisis; Enfermedad renal crónica; SARS-CoV-2; Transplant; Trasplante; Vaccine; Vacuna.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Evolution of COVID-19 in patients undergoing renal replacement therapy in Spain (data from the Spanish COVID-19 Register, updated as of 19 December 2020).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Organización Mundial de la Salud [Accessed 20 Dec 2020]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/2....
    1. Tomazini B.M., Maia I.S., Cavalcanti A.B., Berwanger O., Rosa R.G., Veiga V.C., et al. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA. 2020;324:1307–1316. doi: 10.1001/jama.2020.17021. - DOI - PMC - PubMed
    1. Ministerio de Sanidad; Gobierno de España. [Accessed 19 Dec 2020]. Available from: https://covid19.isciii.es/.
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
    1. Williamson E.J., Walker A.J., Bhaskaran K., Bacon S., Bates C., Morton C.E., et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–436. doi: 10.1038/s41586-020-2521-4. - DOI - PMC - PubMed